CLINICAL GENOMICS: YOUR PARTNER IN EARLIER DETECTION.

InSure® ONE™ is a highly accurate test for detecting blood in fecal samples.

COLVERA™ is a simple blood test designed to detect early recurrence of colorectal cancer.

InSure ONE

InSure ONE is an easy, one-day fecal immunochemical test that uses a sample of water collected with a brush to detect lower GI bleeding.

DETECTING RESIDUAL DISEASE

COLVERA is a clinically validated circulating tumor DNA (ctDNA) blood test designed to detect minimal residual disease after surgical resection in CRC patients.

RECURRENCE MONITORING

COLVERA is a clinically validated ctDNA blood test designed to detect recurrent disease after primary treatment in CRC patients.

TECHNOLOGY

Clinical Genomics harnesses breakthrough science to create innovative and accessible ways to detect disease and enhance lives.

COMPANY

Clinical Genomics is committed to developing and delivering solutions that provide physicians and their patients with information to help guide earlier and better treatment decisions in cancer care management.

CONTACT US

For more information about Clinical Genomics and our products.

Clinical Genomics Pathology Inc. receives licensure from Florida Agency for Healthcare Administration

Clinical Genomics Pathology Inc. receives licensure from Florida Agency for Healthcare Administration Bridgewater, N.J. – March 06, 2018 Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA...

Pivotal study reports InSure® FIT™ offers superior sensitivity for colorectal cancer screening

Pivotal study reports InSure® FIT™ offers superior sensitivity for colorectal cancer screening InSure FIT more sensitive than OC FIT-CHEK and Hemoccult II SENSA for detecting advanced colorectal neoplasia Bridgewater, NJ, February 1, 2018 Clinical...

Clinical Genomics appoints Tadd Lazarus, MD, as Chief Medical Officer

Clinical Genomics appoints Tadd Lazarus, MD, as Chief Medical Officer BRIDGEWATER, N.J., Jan. 18, 2018 Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as...

Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab

Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab Bridgewater, N.J.  – December 19, 2017 Clinical Genomics, a leading provider of liquid biopsy cancer testing solutions, today...

Social Icons

Facebook Twitter LinkedIn

Copyright © 2018 Clinical Genomics Technologies Pty Ltd. All Rights Reserved.